dsm-firmenich partners with SCN BestoCo to inspire a new era in omega-3 gummy innovation

Kaiseraugst (Switzerland), Heerlen (Netherlands)

Leveraging dsm-firmenich’s ingredient and flavor expertise and SCN BestCo’s state-of-the-art gummy development and manufacturing capabilities, the strategic alliance will utilize life’s®OMEGA O33-P100, an algal based omega-3 powder, to craft high-load omega-3 gummies powered by science and sustainability. This breakthrough marks a significant step forward for supplement brands using enjoyable forms in the North American landscape to offer consumers a great tasting alternative to softgels.

A unique omega-3 solution

Omega-3 gummies are historically challenging to formulate due to the sensitive nature of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) – making it difficult to achieve high dosage levels while preserving sensory qualities. Consequently, traditional omega-3 gummy formats typically contain less than 100 mg EPA+DHA per two-piece serving. To help address this, dsm-firmenich introduced life’s®OMEGA O33-P100 to the market. Developed by incorporating life’s®OMEGA oil into innovative POWDER LOC™ technology, this new powder protects the EPA and DHA within a robust shell system; enabling the development of high-performance gummy applications with doses exceeding 400 mg EPA+DHA per two-piece serving.

Breaking boundaries in omega-3 supplementation

dsm-firmenich’s partnership with SCN BestCo – the largest gummy developer and manufacturer globally – will transform omega-3 delivery by making superior gummy formulations a reality for customers in the North America region. Judy Underwood-Brooks, Senior Director of North America Sales at dsm-firmenich comments on the news: “Omega-3s are one of the world’s most well-recognized supplements, prized for their broad benefits in human health. But despite high omega-3 awareness, innovating new formats within this realm has remained challenging – until now. We’re thrilled to embark on this new project with SCN BestCo, with the aim of setting a new standard for gummy-based omega-3 innovation to further unlock the health benefits of these nutrients in novel and appealing ways.”

Not only does the initiative help brands stand out in a sea of softgel products with attractive and convenient supplements, but it also underscores dsm-firmenich’s dedication to upholding the principles of Essential (nutrition), Desirable (taste) and Sustainable (algal) in fostering purpose-led solutions within the human health and nutrition sphere.

Matthew Kemme, Chief Commercial Officer at SCN BestCo adds: “It’s truly an honor to join forces with dsm-firmenich, a global leader in omega-3 advancements. Our rich history of collaboration speaks volumes – being one of the first companies to utilize their MEG-3® omega-3 powder in gummy formats back in 2007, we’ve witnessed firsthand the company’s commitment to innovation in the space. Together, we’re excited to continue breaking new boundaries and deliver the next-generation of omega-3 solutions.”

A premium plant-based alternative

dsm-firmenich’s  life’s®OMEGA is the only commercially available, algal-based omega-3 that delivers EPA and DHA from a single quality source.  life’s®OMEGA solutions are manufactured using proprietary precision fermentation of a natural, non-GMO algae grown in a controlled, enclosed and inland environment to ensure purity, with multiple production locations ensuring a reliable supply. 

To learn more about dsm-firmenich’s life’s®OMEGA brand, visit www.dsm.com/lifes-omega

About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.